Latest Stock Market News

The stock trades at PER of 25.9x on FY24E EPS. The brokerage has maintained ADD Rating on the stock and values the stock at 28x on FY24E earnings, arriving at target price of Rs 3,078/share.

Being the only listed pure-play credit card issuer with significantly higher profitability than Banks and NBFCs (in good times as well as bad times), SBI Cards would continue to command a premium valuation. It has reiterated BUY rating on stock with 12-month target price of Rs 1,260.

The US dollar index, which measures the currency against a basket of six major rivals, was last at 103.44 versus 103.28 at previous close.

On the technical charts, the 200-day moving average of the stock stood at Rs 526.04.

Promoters held 50.73 per cent stake in the company as of 31-Mar-2022, while FII and DII ownership stood at 19.6 per cent and 8.53 per cent, respectively.

Biocon, incorporated in the year 1978, is a Large Cap company (having a market cap of Rs 44314.15 crore) operating in Pharmaceuticals sector.

For the period under review, GHCL registered a rise of 76.63 per cent to Rs 1,273.27 crore as against Rs 720.88 crore during the previous quarter ended March 2021, reports said.

A total of 3,467 shares changed hands on the counter till 11:21AM (IST).

Sanofi reported strong results for Q1CY22 with operating margins expanding 139 bps y-o-y and were better than estimated, leading to a PAT ahead of estimates.

Maruti Suzuki India, incorporated in the year 1981, is a Large Cap company (having a market cap of Rs 233139.35 Crore) operating in Auto sector.